Background: Mesopic conditions elicit both rod and cone responses, and they are more commonly encountered in daily life than are scotopic conditions; yet visual function outcome measures of mesopic visual acuity (VA) or contrast sensitivity (CS) are rarely evaluated. Objective: In retinitis pigmentosa (RP), we explored whether visual reductions in mesopic versus photopic conditions were correlated with cone or rod function, as well as the between-visit test-retest variability in mesopic measures. Methods: At each of two visits, 22 RP subjects completed mesopic and photopic ETDRS VA and Pelli-Robson chart CS tests obtained with and without a U23 NoIR 4% transmission filter; testing of perifoveal scotopic cone or rod sensitivity with the AdaptDx; and the Rabin Cone Contrast Test (CCT). Results: A greater CS reduction in mesopic versus photopic conditions was significantly related to absence of scotopic rod function (p = 0.038) or longer self-reported duration of night vision loss (p = 0.044). VA reductions >0.2 logMAR in mesopic versus photopic conditions were significantly related to reduced cone-mediated scotopic sensitivity (p = 0.038). Significant predictors of the CCT ratio of S-cone to M- and L-cone sensitivity were mesopic VA (p = 0.038) and absence of AdaptDx rod function (p = 0.008). Test-retest 95% coefficients of repeatability were not significantly different when comparing between photopic and mesopic tests of VA (0.16 and 0.12 logMAR, respectively) or CS (0.21 and 0.24 logCS, respectively). Conclusions: Perifoveal scotopic rod and cone function measured with the AdaptDx was significantly correlated with mesopic CS and VA, respectively, which had good, acceptable test-retest repeatability; thus, they appear to be suitable outcome measures to monitor mesopic visual function in clinical practice or trials. RP subjects with reduced mesopic VA and no perifoveal rod function had a greater loss of sensitivity for S-cones than for L-/M-cones.

1.
Hartong
DT
,
Berson
EL
,
Dryja
TP
.
Retinitis pigmentosa
.
Lancet
.
2006
Nov
;
368
(
9549
):
1795
809
.
[PubMed]
0140-6736
2.
Jacobson
SG
,
Roman
AJ
,
Aleman
TS
,
Sumaroka
A
,
Herrera
W
,
Windsor
EA
, et al.
Normal central retinal function and structure preserved in retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
2010
Feb
;
51
(
2
):
1079
85
.
[PubMed]
0146-0404
3.
Massof
RW
,
Finkelstein
D
.
Rod sensitivity relative to cone sensitivity in retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
1979
Mar
;
18
(
3
):
263
72
.
[PubMed]
0146-0404
4.
Iftikhar
M
,
Usmani
B
,
Sanyal
A
,
Kherani
S
,
Sodhi
S
,
Bagheri
S
, et al.
Progression of retinitis pigmentosa on multimodal imaging: The PREP-1 study. Clin Exp Ophthalmol 2018Dec15.
5.
Sayman Muslubas
I
,
Karacorlu
M
,
Arf
S
,
Hocaoglu
M
,
Ersoz
MG
.
Features of the macula and central visual field and fixation pattern in patients with retinitis pigmentosa
.
Retina
.
2018
Feb
;
38
(
2
):
424
31
.
[PubMed]
0275-004X
6.
Cideciyan
A
,
Swider
M
,
Aleman
T
,
Feuer
WJ
,
Schwartz
SB
,
Russell
RC
, et al.
Macular function in macular degenerations: repeatability of microperimetry as a potential outcome measure for ABCA4-associated retinopathy trials.
Invest Ophthalmol Vis Sci
2012
;21;53(2):841-52
7.
Iftikhar
M
,
Kherani
S
,
Kaur
R
,
Lemus
M
,
Nefalar
A
,
Usmani
B
, et al.
Progression of retinitis pigmentosa as measured on microperimetry: the PREP-1 Study
.
Ophthalmol Retina
.
2018
May
;
2
(
5
):
502
7
.
[PubMed]
2468-7219
8.
Kiser
AK
,
Mladenovich
D
,
Eshraghi
F
,
Bourdeau
D
,
Dagnelie
G
.
Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease
.
Optom Vis Sci
.
2005
Nov
;
82
(
11
):
946
54
.
[PubMed]
1040-5488
9.
Sandberg
MA
,
Berson
EL
.
Blue and green cone mechanisms in retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
1977
Feb
;
16
(
2
):
149
57
.
[PubMed]
0146-0404
10.
Swanson
WH
,
Birch
DG
,
Anderson
JL
.
S-cone function in patients with retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
1993
Oct
;
34
(
11
):
3045
55
.
[PubMed]
0146-0404
11.
Greenstein
VC
,
Hood
DC
,
Ritch
R
,
Steinberger
D
,
Carr
RE
.
S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma
.
Invest Ophthalmol Vis Sci
.
1989
Aug
;
30
(
8
):
1732
7
.
[PubMed]
0146-0404
12.
Hood
DC
,
Benimoff
NI
,
Greenstein
VC
.
The response range of the blue-cone pathways: a source of vulnerability to disease
.
Invest Ophthalmol Vis Sci
.
1984
Jul
;
25
(
7
):
864
7
.
[PubMed]
0146-0404
13.
Alexander
KR
,
Hutman
LP
,
Fishman
GA
.
Abnormal foveal spectral sensitivity in retinitis pigmentosa
.
Invest Ophthalmol Vis Sci
.
1987
Apr
;
28
(
4
):
725
30
.
[PubMed]
0146-0404
14.
Ahnelt
PK
,
Kolb
H
,
Pflug
R
.
Identification of a subtype of cone photoreceptor, likely to be blue sensitive, in the human retina
.
J Comp Neurol
.
1987
Jan
;
255
(
1
):
18
34
.
[PubMed]
0021-9967
15.
Hood
DC
,
Greenstein
VC
.
Blue (S) cone pathway vulnerability: a test of a fragile receptor hypothesis
.
Appl Opt
.
1988
Mar
;
27
(
6
):
1025
9
.
[PubMed]
0003-6935
16.
Ferris
FL
 3rd
,
Kassoff
A
,
Bresnick
GH
,
Bailey
I
.
New visual acuity charts for clinical research
.
Am J Ophthalmol
.
1982
Jul
;
94
(
1
):
91
6
.
[PubMed]
0002-9394
17.
Rabin
J
,
Gooch
J
,
Ivan
D
.
Rapid quantification of color vision: the cone contrast test
.
Invest Ophthalmol Vis Sci
.
2011
Feb
;
52
(
2
):
816
20
.
[PubMed]
0146-0404
18.
Kiser
AK
,
Mladenovich
D
,
Eshraghi
F
,
Bourdeau
D
,
Dagnelie
G
.
Reliability and consistency of dark-adapted psychophysical measures in advanced eye disease
.
Invest Ophthalmol Vis Sci
.
2006
Jan
;
47
(
1
):
444
52
.
[PubMed]
0146-0404
19.
Bennett
LD
,
Klein
M
,
Locke
KG
,
Kiser
K
,
Birch
DG
.
Dark-Adapted Chromatic Perimetry for Measuring Rod Visual Fields in Patients with Retinitis Pigmentosa
.
Transl Vis Sci Technol
.
2017
Aug
;
6
(
4
):
15
.
[PubMed]
2164-2591
20.
Bennett
LD
,
Metz
G
,
Klein
M
,
Locke
KG
,
Khwaja
A
,
Birch
DG
.
Regional Variations and Intra-/Intersession Repeatability for Scotopic Sensitivity in Normal Controls and Patients With Inherited Retinal Degenerations
.
Invest Ophthalmol Vis Sci
.
2019
Mar
;
60
(
4
):
1122
31
.
[PubMed]
0146-0404
21.
Koenekoop
RK
.
Why do cone photoreceptors die in rod-specific forms of retinal degenerations?
Ophthalmic Genet
.
2009
Sep
;
30
(
3
):
152
4
.
[PubMed]
1381-6810
22.
Ramachandran
PS
,
Song
JY
,
Bennett
J
.
Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease
.
J Clin Invest
.
2015
Apr
;
125
(
4
):
1390
2
.
[PubMed]
0021-9738
23.
Bovolenta
P
,
Cisneros
E
.
Retinitis pigmentosa: cone photoreceptors starving to death
.
Nat Neurosci
.
2009
Jan
;
12
(
1
):
5
6
.
[PubMed]
1097-6256
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.